Become a Member

Uveitis Development orphan status

By xiexgp, November 20, 2014

I just read (watched) a presentation from Mike Ward of Wall Street Insights & indictments for a biotech newsletter touting a $4 stock for a $28 million California company that has just received (or is about to) orphan status for a new Uveitis drug.

ABBV has one listed, but is a $65 stock.

Any one have a clue as to what this company is?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

12345

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

20 Comments
Inline Feedbacks
View all comments
Guest
DAVID MONTGOMERY
November 21, 2014 4:25 pm

I also spent the hour plus listening to Mr. Wards presentation, not wanting to rush into a $1950 investment on ?. I found this info on Drugs.com.
EDMONTON, March 26 /CNW/ – (ISA:TSX): Isotechnika Inc. today announced that their partner, Lux Biosciences, Inc., reported the results from the three Phase 3 LUMINATE trials investigating voclosporin oral capsule (LUVENIQ(TM) or LX211) for the treatment of uveitis. Voclosporin is a next generation calcineurin inhibitor that Isotechnika has licensed to Lux for ophthalmic indications. The data show a positive effect on ocular inflammation and a safety profile consistent with the expected use in uveitis. Following full analysis of the data, the results of the LUMINATE clinical trials will be submitted for publication and presented at upcoming conferences. In parallel, Lux Biosciences will be preparing submissions for approval.

it sounded like the right drug, but couldn’t pull up the stock quote “ISA:TSX”.
Would be interested in following this thread.

Add a Topic
5554
Add a Topic
5971
Guest
Gord
December 9, 2014 2:19 am

Isa merged with Aurinia and now trades AUP on TSX V… current $4.28…. mkt cap 138 m.

Add a Topic
635
Guest
allan pangallo
January 17, 2015 1:07 pm

The company is Psivida Corporation as of close Friday 1/16/15 a little over $4

Guest
allan pangallo
January 17, 2015 1:10 pm
Reply to  allan pangallo

PSDV is the symbol

Irregular
November 24, 2014 4:44 pm

It was already profiled last week, see above.

👍 255
Guest
Dolfnman
November 26, 2014 11:22 am

I too am listening to this presentation. After some research I believe the company is XOMA.

Guest
Ron Ivens
November 27, 2014 9:06 pm

I too listened to the presentation. He said it was a California based company around $4. Xoma is the only one I found.

Guest
Pesi. D
December 1, 2014 5:24 pm
Guest
Jerry
December 2, 2014 10:14 pm

I found XOMA as well. I thought it was it. So I tried to buy it. But it went up so fast, so I had to buy Market Price. I did buy at 5.40. It fits all the descriptions. About $4 and market value around $28M.

Guest
Jerry
December 2, 2014 10:19 pm
Reply to  Jerry

Correction: About $28M revenue, not market value. It is also an CA company.

Guest
Jerry
December 2, 2014 10:33 pm
Reply to  Jerry

I found some confirmation about this tiny company is indeed XOMA. See the link below:
http://www.stockgumshoe.com/reviews/bioscience-millionaire/rare-move-by-fda-to-ignite-tiny-4-stock-with-a-35-to-1-bang/
Hope we all make a good return. Take care.

Guest
brian
December 4, 2014 10:57 am

Xoma-I looked at insider trading information and fidelity showing a lot of insider selling over the last several months. Also institutional buying slightly positive current quarter at positive 400k and negative previous quarter with net negative 11.5 million shares outflows ?
Thoughts

Add a Topic
3600
jvr052
December 8, 2014 9:19 am

Baker Brothers sold 2,300,000+ shares over 3 days last week. That doesn’t look like cause for optimism.

👍 8
Member
Pat
December 8, 2014 2:49 pm

I looked into this orphan drug claim and it seems to me that there are a few companies that have received Orphan drug status or a cure in trials for a treatment for Uveitis. ABBV has one also XOMA and another is ISA on the TSX I believe ISA was a stock in Toronto that halted trading a few months ago and most likely everyone lost their money.
ABBV trades at $65-$68.00 per share, so there is no one pushing this stock.
I think XOMA is the stock they are pushing and it looks like a classic pump and dump to make someone a lot of money. Just not anyone getting in now.

Add a Topic
5971
Add a Topic
5971
Add a Topic
5971
Guest
Frank64
January 8, 2015 12:37 pm

So Mike Ward is promoting nothing but his 1950. Wish he would donate me 10000 shares since he has such conviction.

Add a Topic
1717
Guest
Al
January 12, 2015 11:01 am

Well, thanks for sharing. And, yes, I did some research also, instead of paying the $1950 fee for the stock’s name. Anyway, I took a gamble today, and bought 500 shares of XOMA today @ $3.72. FYI, as soon as I purchased the shares, it took a dive to $3.59, but it looks like it’s going to recover. lol In my opinion, according to the MACD, it’s going to recover nicely. Good luck to XOMA longs. 🙂

Guest
allan pangallo
January 17, 2015 1:20 pm

Psivida Corp symbol psdv, have no money but have been bugging family and will buy 500 shares Monday. Can only say good luck, I hope

Member
Thomas
January 17, 2015 4:11 pm
Reply to  allan pangallo

And psivida has approvals in several European countries. Yes, I bought some, so beware – I might be a front runner lol.

Member
charles
January 20, 2015 2:16 pm

i also did research…..psivida looked like the stock in the extra long video….i hate those and won’t waste my time watching any more of them…..i did buy psdv and it does show positive on the research and recommendations blog……..i wish i could get my money back on all the foolish investments i’ve made by these so called gurus on the internet…….show me one who really knows and i might listen

Add a Topic
5971

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
17
0
Would love your thoughts, please comment.x
()
x
Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.

Updating your Credit Card in PayPal

Your subscription is paid through your PayPal account.

To update your credit card or cancel, please log in to PayPal.com, go to your automatic payments, open the Stock Gumshoe payment, and make changes there.

More information here: Paypal — What Is an Automatic Payment and How Do I Update or Cancel One?

Exit mobile version